Immunome (IMNM) Cash & Equivalents (2019 - 2026)
Immunome's Cash & Equivalents came in at $217.71 million for Q2 2026, up 51.3% from $143.88 million a year earlier but down 62.6% from the prior quarter.
Powered by 
Analysis
Immunome (IMNM) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Immunome's Cash & Equivalents was $653.48 million, up 355.9% from FY2024.
- Cash & Equivalents has increased in each of the last three years, with a five-year compound annual growth rate of 75.0% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $143.35 million in FY2024 (+45.3%), $98.68 million in FY2023 (+385.6%), $20.32 million in FY2022 (-58.7%) and $49.23 million in FY2021 (+23.8%).
- The five-year range for quarterly Cash & Equivalents is $20.32 million (Q4 2022) to $653.48 million (Q4 2025).
- Year-over-year, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 88.5% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2021 (growth of 734.0%), and the weakest in Q4 2022 (a decline of 58.7%).
- Business Quant data shows IMNM's Cash & Equivalents at $582.7 million (Q1 2026), $653.48 million (Q4 2025) and $272.64 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Immunome | 2.37 Bn | 340.08 Mn | - | 217.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 217.71 Mn |
| Mar 31, 2026 | 582.70 Mn |
| Dec 31, 2025 | 653.48 Mn |
| Sep 30, 2025 | 272.64 Mn |
| Jun 30, 2025 | 143.88 Mn |
| Mar 31, 2025 | 257.61 Mn |
| Dec 31, 2024 | 143.35 Mn |
| Sep 30, 2024 | 155.57 Mn |
| Jun 30, 2024 | 165.33 Mn |
| Mar 31, 2024 | 269.72 Mn |
| Dec 31, 2023 | 98.68 Mn |
| Sep 30, 2023 | 90.64 Mn |
| Jun 30, 2023 | 38.42 Mn |
| Mar 31, 2023 | 44.42 Mn |
| Dec 31, 2022 | 20.32 Mn |
| Sep 30, 2022 | 27.08 Mn |
| Jun 30, 2022 | 34.65 Mn |
| Mar 31, 2022 | 42.88 Mn |
| Dec 31, 2021 | 49.23 Mn |
| Sep 30, 2021 | 56.24 Mn |
API Access
Immunome Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IMNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();